Shortly following the 9/11 terror attack in 2001, letters containing anthrax spores were mailed to news outlets and government buildings killing five people and infecting 17 others. According to a 2012 report, the bioterrorism event cost $3.2 million in cleanup and decontamination. At the time, no testing system was in place that officials could use to screen the letters. Currently, first responders have tests that can provide a screen for dangerous materials in about 24 to 48 hours. Now, researchers at the University of Missouri have worked with a private company to develop a new method for anthrax detection that can identify anthrax in only a few hours.
Normally to identify whether an organism is present, you have to extract the material, culture it, and then pick colonies to examine that might turn out to be anthrax bacteria, says George Stewart, PhD, a medical bacteriologist at MUs Bond Life Sciences Center and chairman of the Department of Veterinary Pathobiology and McKee Endowed Professor within the MU College of Veterinary Medicine. Then you conduct chemical testing which takes some timea minimum of 24 to 48 hours. Using this newly-identified method, we can reduce that time to about five hours.
Using a virus known as a bioluminescent reporter phage, Stewart and graduate student, Krista Spreng, tested the phage at the MU Laboratory for Infectious Disease Research. The phage, developed by David Schofield at Guild BioSciences, a biotech company in Charleston, S.C., is injected in the sample causing anthrax to glow if present. The team also found that the method can detect low levels of anthrax bacteria and rule out false positives. The added benefit to this reporting system is its ability to show if anthrax is present and whether or not the spores are alive, Stewart says.
The next step for the research team at MU and Guild BioSciences will be to get the bioluminescent reporter phage approved by federal regulatory agencies so a product can be produced and distributed, Stewart said.
In the years since the post 9/11 postal attacks, we havent had any bona fide anthrax attacks, Stewart says. That doesnt mean that its not going to happen, we just have to be prepared for when it does occur again.
The research, Bacillus anthracis diagnostic detection and rapid antibiotic susceptibility determination using bioluminescent reporter phage, was funded by the USDA and published in the Journal of Microbiological Methods.
Source: University of Missouri
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
Gag Order Puts Public Health at Risk, APIC Urges Immediate Action
February 4th 2025APIC warns that the HHS gag order on CDC communications endangers public health, delaying critical infection updates and weakening outbreak response amid rising tuberculosis, avian flu, Ebola, and measles threats.
Breaking Barriers: The Future of HIV Prevention and the Fight for Widespread PrEP Access
January 31st 2025Despite medical advances, HIV prevention faces roadblocks—low PrEP adoption, stigma, and accessibility issues threaten progress. Experts push for innovative, long-acting solutions to end the epidemic.